Discover 517 paid clinical trials in Cedar Rapids, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 517
Home-Based Monitoring in Parkinson's Disease
for
Parkinson Disease
Location: Iowa City IA
Sponsor: Jacob E. Simmering
Sex: All
Age: 50 - 70+
Code: NCT06573762
Recruiting
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
for
Advanced Non Small Cell Lung Cancer
Location: Iowa City IA
Sponsor: CellSight Technologies, Inc.
Sex: All
Age: 18+
Code: NCT06107374
Phase 2, Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Iowa City IA, Waukee IA, Peoria IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase 3, Recruiting
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Iowa City IA, Madison WI, Chicago IL, Indianapolis IN,
Sponsor: Dwight Owen
Sex: All
Age: 18+
Code: NCT04919382
Phase 2, Recruiting
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
for
Congenital Myotonic Dystrophy
Location: Iowa City IA, Chicago IL, Little Rock AR, Pittsburgh PA,
Sponsor: AMO Pharma Limited
Sex: All
Age: 6 - 45
Code: NCT05004129
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Limited-duration Teclistamab
for
Myeloma Multiple
Location: Iowa City IA, Little Rock AR, Philadelphia PA,
Adjuvant Steroid Outcomes in Idiopathic Subglottic Stenosis
for
Idiopathic Subglottic Stenosis
Location: Iowa City IA, Nashville TN, Rochester NY, Baltimore MD,
Sponsor: Johns Hopkins University
Sex: All
Age: 18 - 70+
Code: NCT07228104
Phase 3, Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Iowa City IA, Waukee IA, Rochester MN, Chicago IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07518186
Phase 3, Recruiting
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
for
Small Cell Lung Cancer, SCLC,
Location: Iowa City IA, Indianapolis IN, Detroit MI,
Sponsor: Hirva Mamdani
Sex: All
Age: 18+
Code: NCT05903092
Phase 2, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
for
Advanced Renal Cell Carcinoma (RCC)
Location: Iowa City IA, St Louis MO, Cleveland OH,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07293351
Phase 1, Phase 2, Recruiting
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
for
Intracranial Aneurysm
Location: Iowa City IA, Evanston IL, St Louis MO, Carmel IN,
Sponsor: Medtronic Neurovascular Clinical Affairs
Sex: All
Age: 22+
Code: NCT06604884
Recruiting
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
for
Atrial Fibrillation
Location: Iowa City IA, Janesville WI, Rochester MN,
Sponsor: Biosense Webster, Inc.
Sex: All
Age: 22+
Code: NCT07227532
Recruiting
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
for
Heart Failure - NYHA II - IV
Location: Iowa City IA, Hinsdale IL, Sioux Falls SD,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT07069738
Recruiting
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Location: Iowa City IA, Westwood KS, Wichita KS, Birmingham AL,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07190300
Phase 1, Phase 2, Recruiting
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
for
Hemophilia A
Location: Iowa City IA, Aurora CO
Sponsor: Hoffmann-La Roche
Sex: All
Age: 12+
Code: NCT07416526
Phase 3, Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for
Prostate Cancer
Location: Iowa City IA, Milwaukee WI, Chicago IL, Omaha NE,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06855277
Phase 3, Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Iowa City IA, Waukee IA, Rochester MN, Niles IL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase 3, Recruiting
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
for
Hormone-receptor-positive Breast Cancer,
Location: Iowa City IA, Houston TX, Seattle WA
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06756932
Phase 1, Recruiting
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
for
Immunoglobulin A Nephropathy (IgAN)
Location: Iowa City IA, Edina MN, Acworth GA, Denver CO,